How Strategic Collaborations Transform Clinical Diagnostics
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
How Strategic Collaborations Transform Clinical Diagnostics
-
Narrated by:
-
Written by:
About this listen
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss recent industry news and how collaborations are helping drive transformation in clinical diagnostics. Together, they explore:
- Protecting Access to Medicare Act (PAMA) delay (01:09): Dr. Morice shares what the latest delay of PAMA means for laboratories.
- FDA guidance on wearables (02:23): Learn about recent FDA guidance that allows more non‑invasive wearables to be classified as wellness devices.
- Collaboration as a driver of innovation (06:20): Discover why collaboration is critical to advancement in clinical diagnostics.
Note: Information in this post was accurate at the time of its posting.
Resources
- Groundbreaking collaborations
- Mary Jo Williamson offers four steps to maximize collaboration benefits
- Dr. Bill Morice shares how a platform for collaboration transforms diagnostics
- “Answers From the Lab” podcast: “Forging Collaborations That Deliver Better Outcomes”
No reviews yet